<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-16T03:25:37Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/103907" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/103907</identifier><datestamp>2025-03-18T15:13:04Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Dietary Supplements Containing Oat Beta-Glucan and/or Green Coffee (Poly)phenols Showed Limited Effect in Modulating Cardiometabolic Risk Biomarkers in Overweight/Obese Patients without a Lifestyle Intervention</dc:title>
   <dc:creator>García Cordero, Joaquín</dc:creator>
   <dc:creator>Mateos Briz, María Raquel</dc:creator>
   <dc:creator>González Rámila, Susana</dc:creator>
   <dc:creator>Seguido, Miguel A.</dc:creator>
   <dc:creator>Sierra Cinos, José Luis</dc:creator>
   <dc:creator>Bravo, Laura</dc:creator>
   <dc:creator>Sarriá Ruiz, Beatriz Irene</dc:creator>
   <dc:subject>616-056.25</dc:subject>
   <dc:subject>Oat beta-glucan</dc:subject>
   <dc:subject>Green coffee hydroxycinnamates</dc:subject>
   <dc:subject>Obesity</dc:subject>
   <dc:subject>Lipid metabolism</dc:subject>
   <dc:subject>Glucose homeostasis</dc:subject>
   <dc:subject>Dietética y nutrición (Medicina)</dc:subject>
   <dc:subject>3206 Ciencias de la Nutrición</dc:subject>
   <dc:description>2022 Descuento MDPI</dc:description>
   <dc:description>Obesity has reached pandemic proportions and has become a major health concern worldwide. Therefore, it is necessary to find new strategies against this condition and its associated comorbidities. Green coffee polyphenols (GCP) and oat beta-glucans (BGs) have proven their hypolipidaemic and hypoglycaemic effects. This study aimed to examine the effects of the long-term consumption of supplements containing GCP, BG or the novel GCP/BG combination on lipid and glucose metabolism biomarkers in overweight/obese subjects who maintained their dietary habits and physical activity, hence addressing the difficulty that this population faces in adapting to lifestyle changes. A randomised, crossover, blind trial was carried out in 29 volunteers who consumed either GCP (300 mg), BG (2.5 g) or GCP/BG (300 mg + 2.5 g) twice a day for 8 weeks. Blood samples were collected, and blood pressure and body composition were measured at the beginning and end of each intervention. Total cholesterol, triglycerides, high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C), very low-density lipoprotein (VLDL-C) cholesterol, glycated haemoglobin, fasting glucose, insulin, aspartate transaminase, alanine transaminase and different hormones and adipokines were analysed. Only VLDL-C (p = 0.01) and diastolic blood pressure (p = 0.027) decreased after the intervention, especially with the BG supplement. There were no other significant changes in the analysed biomarkers. In conclusion, the regular intake of GCP, BG and GCP/BG without lifestyle changes is not an efficient strategy to improve lipid and glucose homeostasis in overweight/obese subjects.</dc:description>
   <dc:description>Ministerio de Economía, Comercio y Empresa (España)</dc:description>
   <dc:description>Comunidad de Madrid</dc:description>
   <dc:description>Depto. de Nutrición y Ciencia de los Alimentos</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:description>Descuento UCM</dc:description>
   <dc:date>2024-05-10T14:33:46Z</dc:date>
   <dc:date>2024-05-10T14:33:46Z</dc:date>
   <dc:date>2023-05-08</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/103907</dc:identifier>
   <dc:identifier>XXXX-XXXX</dc:identifier>
   <dc:identifier>10.3390/nu15092223</dc:identifier>
   <dc:identifier>2072-6643</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>info:eu-repo/grantAgreement/MINECO//AGL2015-69986-R/ES/EFICACIA DE NUEVOS PRODUCTOS COMBINANDO HIDROXICINAMATOS Y BETA-GLUCANOS COMO HERRAMIENTA DIETETICA FRENTE A OBESIDAD Y DISFUNCIONES ASOCIADAS (HIPERGLICEMIA Y DISLIPEMIA)/</dc:relation>
   <dc:relation>PEJD-2017-PRE_BIO-4225</dc:relation>
   <dc:relation>PEJD-2018-PRE/SAL-9104</dc:relation>
   <dc:relation>García-Cordero, J., Mateos, R., González-Rámila, S., Seguido, M. A., Sierra-Cinos, J. L., Sarriá, B., &amp; Bravo, L. (2023). Dietary Supplements Containing Oat Beta-Glucan and/or Green Coffee (Poly)phenols Showed Limited Effect in Modulating Cardiometabolic Risk Biomarkers in Overweight/Obese Patients without a Lifestyle Intervention. Nutrients, 15(9), 2223. https://doi.org/10.3390/nu15092223</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>MDPI</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>